Vaccinating against Acne: Benefits and Potential Pitfalls

0Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Acne vulgaris is treated with antibiotics and retinoids, but side effects are numerous. Novel safe and efficient therapies are still needed. Wang et al. demonstrate that the secreted virulence factor Christie-Atkins-Munch-Peterson factor 2 from Propionibacterium acnes, a bacterium involved in acne pathogenesis, promotes inflammatory responses. This proinflammatory property could be inhibited by antibodies to Christie-Atkins-Munch-Peterson factor 2, suggesting Christie-Atkins-Munch-Peterson factor 2 as a candidate target in acne vaccination. This work supports the concept of acne immunotherapy, but questions about selection of target antigens remain open.

Cite

CITATION STYLE

APA

Contassot, E. (2018, November 1). Vaccinating against Acne: Benefits and Potential Pitfalls. Journal of Investigative Dermatology. Elsevier B.V. https://doi.org/10.1016/j.jid.2018.06.177

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free